Hayden Michael R Insider Trading Activity

Average Profitability
38.35%
Insider Buys Quantity
14
Insider Buys Sum
$5.81M
Insider Sells Quantity
1
Insider Sells Sum
$2.55M

Insider Activity of Hayden Michael R

According to the SEC Form 4 filings, Hayden Michael R, being in a position of

  1. director at AbCellera Biologics Inc.,
    оver the last 12 months, has bought 100000 shares for $1.05M, and sold 0 shares,
    over all time since 2020-12-15, has bought 297330 shares for $4.27M, and sold 100000 shares for $2.55M.

Biography of Hayden Michael R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $2,110,1764100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-24PurchaseAbCellera Biologics Inc.
ABCL
director
53,613
0.0176%
$10.64$570,442+15.83%
2026-08-12PurchaseAbCellera Biologics Inc.
ABCL
director
46,387
0.0152%
$10.37$481,033+17.08%
2026-07-31PurchaseIonis Pharmaceuticals, Inc.
IONS
director
5,000
0.003%
$51.60$258,000-11.49%
2026-07-30PurchaseIonis Pharmaceuticals, Inc.
IONS
director
15,000
0.0091%
$53.38$800,700-13.87%
2025-05-01PurchaseIonis Pharmaceuticals, Inc.
IONS
director
15,000
0.0095%
$31.86$477,900+125.92%
2024-12-23PurchaseIonis Pharmaceuticals, Inc.
IONS
director
5,000
0.0032%
$36.22$181,079+10.28%
2023-09-22PurchaseAbCellera Biologics Inc.
ABCL
director
20,000
0.0066%
$4.91$98,200-14.3%
2023-08-08PurchaseAbCellera Biologics Inc.
ABCL
director
30,000
0.0104%
$5.90$177,000-23.77%
2021-06-22SaleAbCellera Biologics Inc.
ABCL
director
100,000
0.0424%
$25.50$2.55M-36.66%
2020-12-15PurchaseAbCellera Biologics Inc.
ABCL
director
147,330
0.0394%
$20.00$2.95M-51.21%
2017-08-14PurchaseXenon Pharmaceuticals Inc.
XENE
director
30,000
0.1833%
$2.75$82,494+44.6%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.